Company Profile

ABIOMED Inc (AKA: Applied Biomedical Corporation)
Profile last edited on: 10/10/2023      CAGE: 1LH63      UEI: KBGSE7HJSDE3

Business Identifier: Cardiac assist and replacement devices: leading provider of groundbreaking medical technology providing circulatory and oxygenation support
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

22 Cherry Hill Drive
Danvers, MA 01923
   (978) 646-1400
Location: Multiple
Congr. District: 06
County: Essex

Public Profile

Perhaps among the most name-recognition SBIR participants, ABIOMED was acquired in late December 2022 by Johnson & Johnson - in a deal closed for $16.6B. Involved in SBIR from the very earliest days - of the firm and of the program - and remaining SBIR involved until 2014, ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The firm develops and offers mechanical circulatory support devices and provides a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. More recently - 2017-18 - ABIOMED has made investment (with others) in four promising small firms in development space of interest to them ... so far none being themselves SBIR involved

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $1,291,743
Project Title: Minimally Invasive Pediatric VAD for Treatment of Acute Heart Failure
2010 2 NIH $999,794
Project Title: Minimally Invasive VAD for Treatment of Acute Right Heart Failure
2010 1 NIH $99,665
Project Title: A Novel Polymeric Percutaneous Heart Valve Prosthesis
2010 2 NIH $640,641
Project Title: Intraventricular Cardiac Assist System for Decompression and Recovery
2010 2 NIH $1,318,768
Project Title: Fail-safe TET system for implanted life support devices

Key People / Management

  Michael Minogue -- Chief Executive Officer; President; Chairman

  Marc A Began -- Vice President and General Counsel

  Karim Benali -- Chief Medical Officer

  Seth D Bilazarian

  William J Bolt -- Senior Vice President for Global Quality and Service

  Caitlyn J Bosecker

  Robert Bowen -- Vice President; Chief Financial Officer

  Brian G Connor

  Scott C Corbett -- Biomedical Engineer

  S DeSalvo

  Robert Farra -- Vice President of Manufacturing

  Robert W Fasciano

  Andrew Greenfield -- Vice President of Healthcare Solutions

  Robert Hart

  Michael G Howley -- Vice President and General Manager of Global Sales

  Sharon Kaiser -- Chief Information Officer

  James Koert -- Senior Vice President of Global Product Operations

  Robert T V Kung -- Senior Vice President

  Karen Mahoney -- Head of Global Human Resources

  Stephen McEvoy -- Vice President; Director of Business Development; General Counsel

  Michael T Milbocker

  Alan R Millner

  Timothy E Moutafis

  Burt D Ochs

  Laxmi Peri -- Vice President of Engineering

  Matt Plano -- Vice President, Operations

  Matthew Sibbald

  Thorsten Siess -- Vice President and Chief Technology Officer

  Chuck A Simonton -- Vice President and Chief Medical Officer

  Param I Singh

  Robert B Stewart

  Todd A Trapp -- Vice President and Chief Financial Officer

  David Weber -- Chief Operating Officer

  Andrea Wolga

  Farhad Zarinetchi

  Hong Zhang